Skip to main content
Top
Published in: Journal of Hematology & Oncology 1/2019

Open Access 01-12-2019 | Metastasis | Review

Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression

Authors: Qin Wu, Lingyun Zhou, Duoduo Lv, Xia Zhu, Hong Tang

Published in: Journal of Hematology & Oncology | Issue 1/2019

Login to get access

Abstract

The tumor microenvironment (TME) is an essential intrinsic portion of hepatocellular carcinoma (HCC) for the regulation of its origination, development, invasion, and metastasis. As emerging components of the tumor-host interaction, exosomes are increasingly recognized as professional carriers of information in TME and as pivotal molecular entities involved in tumorigenic microenvironment setup. However, much remains unknown about the role of the exosome communication system within TME in the development and progression of HCC. In this review, we focus on the roles and probable mechanisms of TME in HCC and show the exosome-based immune regulation in TME to promote HCC. Multiple processes are involved in HCC, including tumor survival, growth, angiogenesis, invasion, and metastasis. We also discuss the specific roles of exosomes in HCC processes by molding hospitable TME for HCC, such as providing energy, transmitting protumor signals, and evading inhibitory signals. In addition, exosomes induce angiogenesis by changing the biological characteristics of endothelial cells and directly regulating proangiogenic and propermeability factors. Furthermore, exosomes may lead to HCC metastatic invasion by epithelial-mesenchymal transformation, extracellular matrix degradation, and vascular leakage. Finally, we summarize the therapeutic usage of exosomes in the HCC microenvironment and attempt to provide a theoretical reference for modern antitumor agents designed to target these mechanisms.
Literature
2.
go back to reference Junttila MR, Sauvage FJD. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501:346–54.PubMedCrossRef Junttila MR, Sauvage FJD. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501:346–54.PubMedCrossRef
3.
go back to reference Farazi PA, Depinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–87.PubMedCrossRef Farazi PA, Depinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–87.PubMedCrossRef
4.
go back to reference Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. 2011;17:320–9.PubMedPubMedCentralCrossRef Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. 2011;17:320–9.PubMedPubMedCentralCrossRef
5.
go back to reference Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30:836–48.PubMedPubMedCentralCrossRef Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30:836–48.PubMedPubMedCentralCrossRef
7.
go back to reference Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33:967–78.PubMedCrossRef Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33:967–78.PubMedCrossRef
8.
go back to reference Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25:364–72.PubMedCrossRef Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25:364–72.PubMedCrossRef
9.
go back to reference Pfeffer SR. Unsolved mysteries in membrane traffic. Annu Rev of Biochem. 2007;76:629.CrossRef Pfeffer SR. Unsolved mysteries in membrane traffic. Annu Rev of Biochem. 2007;76:629.CrossRef
11.
go back to reference Record M, Carayon K, Fau - Poirot M, Poirot M, Fau - Silvente-Poirot S, Silvente-Poirot S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta. 2014:108–20.CrossRef Record M, Carayon K, Fau - Poirot M, Poirot M, Fau - Silvente-Poirot S, Silvente-Poirot S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta. 2014:108–20.CrossRef
12.
go back to reference Takayuki K, Wen-Lang L, Yan IK, Chiara B, Tushar P. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 2011;54:1237–48. Takayuki K, Wen-Lang L, Yan IK, Chiara B, Tushar P. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 2011;54:1237–48.
13.
go back to reference Oosthuyzen W, Sime NEL, Ivy JR, Turtle EJ, Street JM, Pound J, et al. Quantification of human urinary exosomes by nanoparticle tracking analysis. J Phys. 2014;229:S247–S47. Oosthuyzen W, Sime NEL, Ivy JR, Turtle EJ, Street JM, Pound J, et al. Quantification of human urinary exosomes by nanoparticle tracking analysis. J Phys. 2014;229:S247–S47.
14.
go back to reference Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. Journal of Translational Medicine,10,1(2012-01-05). 2012;10:5.PubMedPubMedCentralCrossRef Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. Journal of Translational Medicine,10,1(2012-01-05). 2012;10:5.PubMedPubMedCentralCrossRef
15.
go back to reference Lässer C, Alikhani VS, Ekström K, Eldh M, Paredes PT, Bossios A, et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med. 2011;9:9.PubMedPubMedCentralCrossRef Lässer C, Alikhani VS, Ekström K, Eldh M, Paredes PT, Bossios A, et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med. 2011;9:9.PubMedPubMedCentralCrossRef
16.
go back to reference Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol. 2012;44:2060–4.PubMedCrossRef Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol. 2012;44:2060–4.PubMedCrossRef
17.
go back to reference Sun D, Fau ZX. Zhang S, Zhang S Fau - Deng Z-B, Deng Zb Fau - Grizzle W, Grizzle W Fau - Miller D, Miller D Fau - Zhang H-G, et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv Drug Deliv Rev. 2013:342–7.PubMedCrossRef Sun D, Fau ZX. Zhang S, Zhang S Fau - Deng Z-B, Deng Zb Fau - Grizzle W, Grizzle W Fau - Miller D, Miller D Fau - Zhang H-G, et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv Drug Deliv Rev. 2013:342–7.PubMedCrossRef
18.
go back to reference Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012;1820:940–8.PubMedCrossRef Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012;1820:940–8.PubMedCrossRef
19.
go back to reference Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013;32:623–42.PubMedCrossRef Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013;32:623–42.PubMedCrossRef
20.
go back to reference Masyuk AI, Huang BQ, Ward CJ, Gradilone SA, Banales JM, Masyuk TV, et al. Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol. 2010;299:990–9.CrossRef Masyuk AI, Huang BQ, Ward CJ, Gradilone SA, Banales JM, Masyuk TV, et al. Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol. 2010;299:990–9.CrossRef
21.
go back to reference Zhong-Bin D, Xiaoying Z, Songwen J, Xiaoyu X, Jingyao M, Qilong W, et al. Intestinal mucus-derived nanoparticle-mediated activation of Wnt/β-catenin signaling plays a role in induction of liver natural killer T cell anergy in mice. Hepatology. 2013;57:1250–61.CrossRef Zhong-Bin D, Xiaoying Z, Songwen J, Xiaoyu X, Jingyao M, Qilong W, et al. Intestinal mucus-derived nanoparticle-mediated activation of Wnt/β-catenin signaling plays a role in induction of liver natural killer T cell anergy in mice. Hepatology. 2013;57:1250–61.CrossRef
22.
go back to reference Fonsato V, Fau CF. Herrera MB, Herrera Mb Fau - Cavallari C, Cavallari C Fau - Deregibus MC, Deregibus Mc Fau - Cisterna B, Cisterna B Fau - Bruno S, et al. Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumour microRNAs. Stem Cells. 2012:1985–98. Fonsato V, Fau CF. Herrera MB, Herrera Mb Fau - Cavallari C, Cavallari C Fau - Deregibus MC, Deregibus Mc Fau - Cisterna B, Cisterna B Fau - Bruno S, et al. Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumour microRNAs. Stem Cells. 2012:1985–98.
23.
go back to reference Witek RP, Yang L, Liu R, Jung Y, Omenetti A, Syn WK, et al. Liver cell–derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology. 2009;136:320–30 e2.PubMedCrossRef Witek RP, Yang L, Liu R, Jung Y, Omenetti A, Syn WK, et al. Liver cell–derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology. 2009;136:320–30 e2.PubMedCrossRef
25.
go back to reference Greuter T, Shah VH. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J Gastroenterol. 2016;51:511–9.PubMedCrossRef Greuter T, Shah VH. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights. J Gastroenterol. 2016;51:511–9.PubMedCrossRef
26.
go back to reference Royo F, Schlangen K, Palomo L, Gonzalez E, Condevancells J, Berisa A, et al. Transcriptome of extracellular vesicles released by hepatocytes. Plos One. 2013;8:e68693.PubMedPubMedCentralCrossRef Royo F, Schlangen K, Palomo L, Gonzalez E, Condevancells J, Berisa A, et al. Transcriptome of extracellular vesicles released by hepatocytes. Plos One. 2013;8:e68693.PubMedPubMedCentralCrossRef
27.
go back to reference Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, et al. Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes. Gastroenterology. 2016;150:956–67.PubMedCrossRef Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, et al. Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes. Gastroenterology. 2016;150:956–67.PubMedCrossRef
29.
go back to reference Kouwaki T, Okamoto M, Tsukamoto H, Fukushima Y, Oshiumi H. Extracellular vesicles deliver host and virus RNA and regulate innate immune response. Int J Mol Sci. 2017;18:666.PubMedCentralCrossRef Kouwaki T, Okamoto M, Tsukamoto H, Fukushima Y, Oshiumi H. Extracellular vesicles deliver host and virus RNA and regulate innate immune response. Int J Mol Sci. 2017;18:666.PubMedCentralCrossRef
30.
go back to reference Momen-Heravi F, Saha B, Kodys K, Catalano D, Satishchandran A, Szabo G. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. J Transl Med. 2015;13:1–13.CrossRef Momen-Heravi F, Saha B, Kodys K, Catalano D, Satishchandran A, Szabo G. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. J Transl Med. 2015;13:1–13.CrossRef
31.
go back to reference Saha B, Momen-Heravi F, Kodys K, Szabo G. MicroRNA cargo of extracellular vesicles from alcohol-exposed monocytes signals naive monocytes to differentiate into M2 macrophages. J Biol Chem. 2016;291:149–59.PubMedCrossRef Saha B, Momen-Heravi F, Kodys K, Szabo G. MicroRNA cargo of extracellular vesicles from alcohol-exposed monocytes signals naive monocytes to differentiate into M2 macrophages. J Biol Chem. 2016;291:149–59.PubMedCrossRef
32.
go back to reference Li C, Alyssa C, Yu Z, Ruju C, Bo Y, Kitty A, et al. Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology. 2014;59:1118–29.CrossRef Li C, Alyssa C, Yu Z, Ruju C, Bo Y, Kitty A, et al. Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology. 2014;59:1118–29.CrossRef
33.
go back to reference El–Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.PubMedCrossRef El–Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.PubMedCrossRef
34.
go back to reference Blum HE, Moradpour D. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27.CrossRef Blum HE, Moradpour D. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27.CrossRef
35.
go back to reference Leonardi GC, Candido S, Cervello M, Nicolosi D, Raiti F, Travali S, et al. The tumour microenvironment in hepatocellular carcinoma (review). Int J Oncol. 2012;40:1733.PubMed Leonardi GC, Candido S, Cervello M, Nicolosi D, Raiti F, Travali S, et al. The tumour microenvironment in hepatocellular carcinoma (review). Int J Oncol. 2012;40:1733.PubMed
36.
go back to reference Feingold M, ., Hall BD, Lacassie Y, ., Martínez-Frías ML. Syndrome of microcephaly, facial and hand abnormalities, tracheoesophageal fistula, duodenal atresia, and developmental delay. Am J Med Genet A. 1997;69:571-582.CrossRef Feingold M, ., Hall BD, Lacassie Y, ., Martínez-Frías ML. Syndrome of microcephaly, facial and hand abnormalities, tracheoesophageal fistula, duodenal atresia, and developmental delay. Am J Med Genet A. 1997;69:571-582.CrossRef
37.
go back to reference Hellerbrand C. Hepatic stellate cells—the pericytes in the liver. Pflügers Archiv:Eur J Physiol. 2013;465:775–8.CrossRef Hellerbrand C. Hepatic stellate cells—the pericytes in the liver. Pflügers Archiv:Eur J Physiol. 2013;465:775–8.CrossRef
38.
go back to reference Amann T, Bataille F, Spruss T, Mühlbauer M, Gäbele E, Schölmerich J, et al. Activated hepatic stellate cells promote tumourigenicity of hepatocellular carcinoma. Cancer Sci. 2010;100:646–53.CrossRef Amann T, Bataille F, Spruss T, Mühlbauer M, Gäbele E, Schölmerich J, et al. Activated hepatic stellate cells promote tumourigenicity of hepatocellular carcinoma. Cancer Sci. 2010;100:646–53.CrossRef
39.
go back to reference Xiong S, Wang R, Chen Q, Luo J, Wang J, Zhao Z, et al. Cancer-associated fibroblasts promote stem cell-like properties of hepatocellular carcinoma cells through IL-6/STAT3/Notch signaling. Am J Cancer Res. 2018;8:302–16.PubMedPubMedCentral Xiong S, Wang R, Chen Q, Luo J, Wang J, Zhao Z, et al. Cancer-associated fibroblasts promote stem cell-like properties of hepatocellular carcinoma cells through IL-6/STAT3/Notch signaling. Am J Cancer Res. 2018;8:302–16.PubMedPubMedCentral
40.
go back to reference Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, et al. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene. 2011;30:1351–9.PubMedCrossRef Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, et al. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene. 2011;30:1351–9.PubMedCrossRef
41.
43.
go back to reference Zhang S, Sun WY, Wu JJ, Wei W. TGF-beta signaling pathway as a pharmacological target in liver diseases. Pharmacol Res. 2014;85:15–22.PubMedCrossRef Zhang S, Sun WY, Wu JJ, Wei W. TGF-beta signaling pathway as a pharmacological target in liver diseases. Pharmacol Res. 2014;85:15–22.PubMedCrossRef
44.
go back to reference Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 2004;30:398–408.PubMedCrossRef Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 2004;30:398–408.PubMedCrossRef
45.
go back to reference Lippolis C, Refolo MG, D'Alessandro R, Carella N, Messa C, Cavallini A, et al. Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1. J Exp Clin Cancer Res. 2015;34:90.PubMedPubMedCentralCrossRef Lippolis C, Refolo MG, D'Alessandro R, Carella N, Messa C, Cavallini A, et al. Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1. J Exp Clin Cancer Res. 2015;34:90.PubMedPubMedCentralCrossRef
46.
go back to reference Streuli CH, Akhtar N. Signal co-operation between integrins and other receptor systems. Biochem J. 2009;418:491–506.PubMedCrossRef Streuli CH, Akhtar N. Signal co-operation between integrins and other receptor systems. Biochem J. 2009;418:491–506.PubMedCrossRef
47.
go back to reference Hanahan D, Coussens L. Accessories to the crime: functions of cells recruited to the tumour microenvironment. Cancer Cell. 2012;21:309–22.PubMedCrossRef Hanahan D, Coussens L. Accessories to the crime: functions of cells recruited to the tumour microenvironment. Cancer Cell. 2012;21:309–22.PubMedCrossRef
48.
go back to reference Pengfei L, Weaver VM, Zena W. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395.CrossRef Pengfei L, Weaver VM, Zena W. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395.CrossRef
49.
go back to reference Chen J, Wang Q, Xh HX, Chen X, Cao L, Chen L, et al. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9. Hepatol Res. 2010;39:177–86.CrossRef Chen J, Wang Q, Xh HX, Chen X, Cao L, Chen L, et al. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9. Hepatol Res. 2010;39:177–86.CrossRef
50.
go back to reference Fang T, Lv H, Lv G, Li T, Wang C, Han Q, et al. Tumour-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9:191.PubMedPubMedCentralCrossRef Fang T, Lv H, Lv G, Li T, Wang C, Han Q, et al. Tumour-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9:191.PubMedPubMedCentralCrossRef
51.
go back to reference María M, Cristina GV, Carolina VB, Susana G, Fátima SC, Ángel GM, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun. 2011;2:282.CrossRef María M, Cristina GV, Carolina VB, Susana G, Fátima SC, Ángel GM, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun. 2011;2:282.CrossRef
52.
go back to reference Moris D, Lu L, Qian S. Mechanisms of liver-induced tolerance. Curr Opin Organ Transplant. 2017;22:71.PubMed Moris D, Lu L, Qian S. Mechanisms of liver-induced tolerance. Curr Opin Organ Transplant. 2017;22:71.PubMed
53.
go back to reference Yang N, Li S, Li G, Zhang S, Tang X, Ni S, et al. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma. Oncotarget. 2016;8:3683.PubMedCentral Yang N, Li S, Li G, Zhang S, Tang X, Ni S, et al. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma. Oncotarget. 2016;8:3683.PubMedCentral
54.
55.
go back to reference Wang X, Shen H, Zhangyuan G, Huang R, Zhang W, He Q, et al. 14-3-3zeta delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumour function of tumour-infiltrating T lymphocytes. Cell Death Dis. 2018:159. Wang X, Shen H, Zhangyuan G, Huang R, Zhang W, He Q, et al. 14-3-3zeta delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumour function of tumour-infiltrating T lymphocytes. Cell Death Dis. 2018:159.
56.
57.
go back to reference Nadia G, Xim TY, Joncker NT, Augustine C, Fermin G, Na X, et al. NKG2D-deficient mice are defective in tumour surveillance in models of spontaneous malignancy. Immunity. 2008;28:571–80.CrossRef Nadia G, Xim TY, Joncker NT, Augustine C, Fermin G, Na X, et al. NKG2D-deficient mice are defective in tumour surveillance in models of spontaneous malignancy. Immunity. 2008;28:571–80.CrossRef
58.
go back to reference Omodele A, Philippe B, Lola FM, Sonia AG, Skepper JN, Mar VG, et al. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumour cells in exosomes. Cancer Res. 2010;70:481–9.CrossRef Omodele A, Philippe B, Lola FM, Sonia AG, Skepper JN, Mar VG, et al. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumour cells in exosomes. Cancer Res. 2010;70:481–9.CrossRef
59.
go back to reference Rao Q, Zuo B, Lu Z, Gao X, You A, Wu C, et al. Tumour-derived exosomes elicit tumour suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology. 2016;64:456–72.PubMedCrossRef Rao Q, Zuo B, Lu Z, Gao X, You A, Wu C, et al. Tumour-derived exosomes elicit tumour suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology. 2016;64:456–72.PubMedCrossRef
60.
go back to reference Chow A, Zhou W, Liu L, Fong MY, Champer J, Van Haute D, et al. Macrophage immunomodulation by breast cancer-derived exosomes requires toll-like receptor 2-mediated activation of NF-kappaB. Sci Rep. 2014;4:5750.PubMedPubMedCentralCrossRef Chow A, Zhou W, Liu L, Fong MY, Champer J, Van Haute D, et al. Macrophage immunomodulation by breast cancer-derived exosomes requires toll-like receptor 2-mediated activation of NF-kappaB. Sci Rep. 2014;4:5750.PubMedPubMedCentralCrossRef
61.
go back to reference Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816–26.PubMedPubMedCentralCrossRef Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816–26.PubMedPubMedCentralCrossRef
62.
go back to reference Yu L. Exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through STAT3 pathway in macrophages. Int J Biol Sci. 2017;13:723–34.PubMedPubMedCentralCrossRef Yu L. Exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through STAT3 pathway in macrophages. Int J Biol Sci. 2017;13:723–34.PubMedPubMedCentralCrossRef
63.
go back to reference Xiong L, Zhen S, Yu Q, Gong Z. HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs. Oncol Lett. 2017;14:2141–6.PubMedPubMedCentralCrossRef Xiong L, Zhen S, Yu Q, Gong Z. HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs. Oncol Lett. 2017;14:2141–6.PubMedPubMedCentralCrossRef
64.
go back to reference Aucher A, Rudnicka D, Davis DM. MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation. J Immunol. 2013;191:6250–60.PubMedCrossRef Aucher A, Rudnicka D, Davis DM. MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation. J Immunol. 2013;191:6250–60.PubMedCrossRef
65.
go back to reference Kenji T, Yan IK, Hiroaki H, Tushar P. Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci. 2014;127:1585–94.CrossRef Kenji T, Yan IK, Hiroaki H, Tushar P. Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci. 2014;127:1585–94.CrossRef
66.
go back to reference Takahashi K, Yan IK, Kogure T, Haga H, Patel T. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio. 2014:458–67.PubMedPubMedCentralCrossRef Takahashi K, Yan IK, Kogure T, Haga H, Patel T. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio. 2014:458–67.PubMedPubMedCentralCrossRef
67.
go back to reference Chao C, Fei L, Liu X, Lu L, Hui X, Yang Q, et al. NF-kB-regulated exosomal miR-155 promotes the inflammation associated with arsenite carcinogenesis. Cancer Lett. 2017;388:21–33.CrossRef Chao C, Fei L, Liu X, Lu L, Hui X, Yang Q, et al. NF-kB-regulated exosomal miR-155 promotes the inflammation associated with arsenite carcinogenesis. Cancer Lett. 2017;388:21–33.CrossRef
68.
go back to reference Fu XT, Shi YH, Zhou J, Peng YF, Liu WR, Shi GM, et al. MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma. Cancer Lett. 2018;412:53763–79. Fu XT, Shi YH, Zhou J, Peng YF, Liu WR, Shi GM, et al. MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma. Cancer Lett. 2018;412:53763–79.
69.
go back to reference Zhang Z, Xiao L, Wei S, Yue S, Yang J, Li J, et al. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Cancer Lett. 2017;397:33–42.PubMedCrossRef Zhang Z, Xiao L, Wei S, Yue S, Yang J, Li J, et al. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Cancer Lett. 2017;397:33–42.PubMedCrossRef
70.
go back to reference Sudarshana B, Bhattacharyya SN. Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells. Nucleic Acids Res. 2014;42:7170–85.CrossRef Sudarshana B, Bhattacharyya SN. Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells. Nucleic Acids Res. 2014;42:7170–85.CrossRef
71.
go back to reference Lou G, Song X, Yang F, Wu S, Wang J, Chen Z, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015;8:122.PubMedPubMedCentralCrossRef Lou G, Song X, Yang F, Wu S, Wang J, Chen Z, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015;8:122.PubMedPubMedCentralCrossRef
72.
go back to reference Tang J, Li Y, Liu K, Zhu Q, Yang WH, Xiong LK, et al. Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma. Minerva Medica. 2018;109. Tang J, Li Y, Liu K, Zhu Q, Yang WH, Xiong LK, et al. Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma. Minerva Medica. 2018;109.
73.
go back to reference Aixue H, Jie D, Shaohua L, Chaonan W, Hongmei D, Hui L, et al. Exosomal transfer of vasorin expressed in hepatocellular carcinoma cells promotes migration of human umbilical vein endothelial cells. Int J Biol Sci. 2015;11:961–9.CrossRef Aixue H, Jie D, Shaohua L, Chaonan W, Hongmei D, Hui L, et al. Exosomal transfer of vasorin expressed in hepatocellular carcinoma cells promotes migration of human umbilical vein endothelial cells. Int J Biol Sci. 2015;11:961–9.CrossRef
74.
go back to reference Yukawa H, Suzuki K, Aoki K, Arimoto T, Yasui T, Kaji N, et al. Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells. Sci Rep. 2018;8. Yukawa H, Suzuki K, Aoki K, Arimoto T, Yasui T, Kaji N, et al. Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells. Sci Rep. 2018;8.
75.
go back to reference Lin XJ, Fang JH, Yang XJ, Zhang C, Yuan Y, Zheng L, et al. Hepatocellular carcinoma cell-secreted exosomal microRNA-210 promotes angiogenesis in vitro and in vivo. Mol Ther Nucleic Acids. 2018:243–52.PubMedPubMedCentralCrossRef Lin XJ, Fang JH, Yang XJ, Zhang C, Yuan Y, Zheng L, et al. Hepatocellular carcinoma cell-secreted exosomal microRNA-210 promotes angiogenesis in vitro and in vivo. Mol Ther Nucleic Acids. 2018:243–52.PubMedPubMedCentralCrossRef
76.
go back to reference Conigliaro A, Costa V, Dico AL, Saieva L, Buccheri S, Dieli F, et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Molecular Cancer. 2015;14:155.PubMedPubMedCentralCrossRef Conigliaro A, Costa V, Dico AL, Saieva L, Buccheri S, Dieli F, et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Molecular Cancer. 2015;14:155.PubMedPubMedCentralCrossRef
77.
go back to reference Wu Z, Zeng Q, Cao K, Sun Y. Exosomes: small vesicles with big roles in hepatocellular carcinoma. Oncotarget. 2016;7:60687–97.PubMedPubMedCentral Wu Z, Zeng Q, Cao K, Sun Y. Exosomes: small vesicles with big roles in hepatocellular carcinoma. Oncotarget. 2016;7:60687–97.PubMedPubMedCentral
78.
go back to reference Prasanna Kumar S, Das SK, Rachel G, Dong C, Jyoti S, Chadia R, et al. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumour angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221. J Biol Chem. 2012;287:13952.CrossRef Prasanna Kumar S, Das SK, Rachel G, Dong C, Jyoti S, Chadia R, et al. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumour angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221. J Biol Chem. 2012;287:13952.CrossRef
79.
go back to reference Ning Z, Wei-Dong D, Jian-Jun L, Liang Z, Xing W, Yin-Zhe X, et al. STAT3 regulates the migration and invasion of a stem-like subpopulation through microRNA-21 and multiple targets in hepatocellular carcinoma. Oncol Reports. 2015;33:1493–8.CrossRef Ning Z, Wei-Dong D, Jian-Jun L, Liang Z, Xing W, Yin-Zhe X, et al. STAT3 regulates the migration and invasion of a stem-like subpopulation through microRNA-21 and multiple targets in hepatocellular carcinoma. Oncol Reports. 2015;33:1493–8.CrossRef
80.
go back to reference Zhen Q, Wu J, Wu J, Luo D, Jiang C, Ding Y. Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro. J Exp Clin Cancer Res. 2016;35:159.CrossRef Zhen Q, Wu J, Wu J, Luo D, Jiang C, Ding Y. Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro. J Exp Clin Cancer Res. 2016;35:159.CrossRef
81.
go back to reference Karaosmanoğlu O, Banerjee S, Sivas H. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells. Cell Oncol. 2018:1–15. Karaosmanoğlu O, Banerjee S, Sivas H. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells. Cell Oncol. 2018:1–15.
82.
go back to reference Mian H, Hao Q, Poon TCW, Siu-Ching S, Xiaofan D, Ngai Na C, et al. Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. Carcinogenesis. 2015;36:1008–18.CrossRef Mian H, Hao Q, Poon TCW, Siu-Ching S, Xiaofan D, Ngai Na C, et al. Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. Carcinogenesis. 2015;36:1008–18.CrossRef
83.
go back to reference Fang JH, Zhang ZJ, Shang LR, Luo YW, Lin Y, Yuan Y, et al. Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins. Hepatology. 2018. Fang JH, Zhang ZJ, Shang LR, Luo YW, Lin Y, Yuan Y, et al. Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins. Hepatology. 2018.
84.
go back to reference Lu Z, Zuo B, Jing R, Gao X, Rao Q, Liu Z, et al. Dendritic cell-derived exosomes elicit tumour regression in autochthonous hepatocellular carcinoma mouse models. J Hepatol. 2017;67:739–48.PubMedCrossRef Lu Z, Zuo B, Jing R, Gao X, Rao Q, Liu Z, et al. Dendritic cell-derived exosomes elicit tumour regression in autochthonous hepatocellular carcinoma mouse models. J Hepatol. 2017;67:739–48.PubMedCrossRef
85.
go back to reference Lv LH, Wan YL, Lin Y, Zhang W, Yang M, Li GL, et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumour responses in vitro. J Biol Chem. 2012;287:15874–85.PubMedPubMedCentralCrossRef Lv LH, Wan YL, Lin Y, Zhang W, Yang M, Li GL, et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumour responses in vitro. J Biol Chem. 2012;287:15874–85.PubMedPubMedCentralCrossRef
86.
go back to reference Poggio M, Hu T, Pai CC, Chu B, Belair CD, Chang A, et al. Suppression of exosomal PD-L1 induces systemic anti-tumour immunity and memory. Cell. 2019;177:414–27 e13.PubMedPubMedCentralCrossRef Poggio M, Hu T, Pai CC, Chu B, Belair CD, Chang A, et al. Suppression of exosomal PD-L1 induces systemic anti-tumour immunity and memory. Cell. 2019;177:414–27 e13.PubMedPubMedCentralCrossRef
87.
go back to reference Liang G, Kan S, Zhu Y, Feng S, Feng W, Gao S. Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells. Int J Nanomedicine. 2018;13:585–99.PubMedPubMedCentralCrossRef Liang G, Kan S, Zhu Y, Feng S, Feng W, Gao S. Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells. Int J Nanomedicine. 2018;13:585–99.PubMedPubMedCentralCrossRef
88.
go back to reference Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumour therapy. Biomaterials. 2014;35:2383–90.PubMedCrossRef Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumour therapy. Biomaterials. 2014;35:2383–90.PubMedCrossRef
89.
go back to reference Takahashi K, Yan IK, Wood J, Haga H, Patel T. Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumour cell responses to chemotherapy. Mol Cancer Res. 2014;12:1377–87.PubMedPubMedCentralCrossRef Takahashi K, Yan IK, Wood J, Haga H, Patel T. Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumour cell responses to chemotherapy. Mol Cancer Res. 2014;12:1377–87.PubMedPubMedCentralCrossRef
90.
go back to reference Balamurugan K. HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer J Int Du Cancer. 2016;138:1058–66.CrossRef Balamurugan K. HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer J Int Du Cancer. 2016;138:1058–66.CrossRef
91.
go back to reference Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver. Hepatology. 2001;34:859–67.PubMedCrossRef Bissell DM, Roulot D, George J. Transforming growth factor beta and the liver. Hepatology. 2001;34:859–67.PubMedCrossRef
92.
go back to reference Yoshida K, Matsuzaki K, Murata M, Yamaguchi T, Suwa K, Okazaki K. Clinico-pathological importance of TGF-β/phospho-smad signaling during human hepatic fibrocarcinogenesis. Cancers. 2018;10:183.PubMedCentralCrossRef Yoshida K, Matsuzaki K, Murata M, Yamaguchi T, Suwa K, Okazaki K. Clinico-pathological importance of TGF-β/phospho-smad signaling during human hepatic fibrocarcinogenesis. Cancers. 2018;10:183.PubMedCentralCrossRef
93.
go back to reference Seo W, Eun HS, Kim SY, Yi HS, Lee YS, Park SH, et al. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis. Hepatology. 2016;64:616.PubMedCrossRef Seo W, Eun HS, Kim SY, Yi HS, Lee YS, Park SH, et al. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis. Hepatology. 2016;64:616.PubMedCrossRef
94.
go back to reference Xu QG, Yu J, Guo XG, Hou GJ, Yuan SX, Yang Y, et al. IL-17A promotes the invasion–metastasis cascade via theAKTpathway in hepatocellular carcinoma. Mol Oncol. 2018;12:936–52.PubMedPubMedCentralCrossRef Xu QG, Yu J, Guo XG, Hou GJ, Yuan SX, Yang Y, et al. IL-17A promotes the invasion–metastasis cascade via theAKTpathway in hepatocellular carcinoma. Mol Oncol. 2018;12:936–52.PubMedPubMedCentralCrossRef
95.
go back to reference Liu Z, Tu K, Liu Q. Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma. Febs Lett. 2016;588:3089–97.CrossRef Liu Z, Tu K, Liu Q. Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma. Febs Lett. 2016;588:3089–97.CrossRef
96.
go back to reference Chen J, Yue Y, Shu L, Liu Y, Shu Z, Cao S, et al. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy. J Cell Mol Med. 2017;21. Chen J, Yue Y, Shu L, Liu Y, Shu Z, Cao S, et al. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy. J Cell Mol Med. 2017;21.
97.
go back to reference Wei-Chih T, Paul Wei-Che H, Tsung-Ching L, Gar-Yang C, Ching-Wen L, Chun-Ming C, et al. MicroRNA-122, a tumour suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2010;49:1571–82. Wei-Chih T, Paul Wei-Che H, Tsung-Ching L, Gar-Yang C, Ching-Wen L, Chun-Ming C, et al. MicroRNA-122, a tumour suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2010;49:1571–82.
98.
go back to reference Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011;146:873–87.PubMedCrossRef Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011;146:873–87.PubMedCrossRef
99.
go back to reference Samy L, Jian X, Rik D. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.CrossRef Samy L, Jian X, Rik D. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.CrossRef
100.
go back to reference Muh-Hwa Y, Chih-Li C, Gar-Yang C, Shih-Hwa C, Chien-Wei S, Teh-Ying C, et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology. 2010;50:1464–74. Muh-Hwa Y, Chih-Li C, Gar-Yang C, Shih-Hwa C, Chien-Wei S, Teh-Ying C, et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology. 2010;50:1464–74.
102.
go back to reference Whittaker S, Marais R Fau - Zhu AX, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 2010:4989–5005.PubMedCrossRef Whittaker S, Marais R Fau - Zhu AX, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 2010:4989–5005.PubMedCrossRef
103.
go back to reference Goessler UR, Hörmann K, Riedel F. Tissue engineering with chondrocytes and function of the extracellular matrix (review). Int J Mol Med. 2004;13:505.PubMed Goessler UR, Hörmann K, Riedel F. Tissue engineering with chondrocytes and function of the extracellular matrix (review). Int J Mol Med. 2004;13:505.PubMed
104.
go back to reference Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004;84:869–901.PubMedCrossRef Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004;84:869–901.PubMedCrossRef
106.
go back to reference Page DB, Postow MA, Callahan MK, Allison JP, Wolchok JD. Immune modulation in cancer with antibodies. Annu Rev Med. 2014;65:185–202.PubMedCrossRef Page DB, Postow MA, Callahan MK, Allison JP, Wolchok JD. Immune modulation in cancer with antibodies. Annu Rev Med. 2014;65:185–202.PubMedCrossRef
107.
go back to reference Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res. 2015;32:2003–14.PubMedPubMedCentralCrossRef Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res. 2015;32:2003–14.PubMedPubMedCentralCrossRef
108.
go back to reference Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B. 2016;6:287–96.PubMedPubMedCentralCrossRef Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B. 2016;6:287–96.PubMedPubMedCentralCrossRef
109.
go back to reference Vlashi E, Pajonk F. Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol. 2015;31:28–35.PubMedCrossRef Vlashi E, Pajonk F. Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol. 2015;31:28–35.PubMedCrossRef
110.
go back to reference Zhaolin C, Tianlu S, Lei Z, Pengli Z, Mingying D, Cheng H, et al. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett. 2016;370:153–64.CrossRef Zhaolin C, Tianlu S, Lei Z, Pengli Z, Mingying D, Cheng H, et al. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett. 2016;370:153–64.CrossRef
Metadata
Title
Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
Authors
Qin Wu
Lingyun Zhou
Duoduo Lv
Xia Zhu
Hong Tang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2019
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/s13045-019-0739-0

Other articles of this Issue 1/2019

Journal of Hematology & Oncology 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine